|
Session 172
Poster Abstracts
Hepatitis C Co-infection: Markers, Outcome and Effect of ART
Tuesday, 1-4 pm
Room: Hall B |
1057
 |
Factors Associated with Survival and First Hepatic Decompensation in a Large Prospective Cohort of HIV/HCV-co-infected Patients with Liver Cirrhosis
M Lopez-Dieguez1, M Montes2, C Quereda3, M Von Wichmann4, J Berenguer5, J Pascual2, C Tural6, F Pulido7, H Esteban8, Jose Arribas*2, and GESIDA 37/03-FIPSE 36465/03 Study Group
1Hosp Clin, Barcelona, Spain; 2Hosp La Paz, Madrid, Spain; 3Hosp Ramon y Cajal, Madrid, Spain; 4Hosp Donostia, San Sebastian, Spain; 5Hosp Gregorio Maranon, Madrid, Spain; 6Hosp Germans Trials i Pujol, Badalona, Spain; 7Hosp 12 de Octubre, Madrid, Spain; and 8ACE, GESIDA, Madrid, Spain |
| 1058 |
Effect of Hepatitis C Viremia on HIV-infected Individuals in Nigeria
Nimzing Ladep Gwamzhi*1, C Hawkins2, S Meloni3, M Muazu1, B Badung1, R Chung4, P Kanki3, E Ekong5, J Idoko1, and C Graham6
1Jos Univ Teaching Hosp, Plateau, Nigeria; 2Feinberg Sch of Med, Northwestern Univ, Chicago, IL, US; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4Massachusetts Gen Hosp, Boston, US; 5Military Reference Hosp, Lagos, Nigeria; and 6Beth Israel Deaconess Med Ctr, Boston, MA, US |
1059
|
Natural History of Compensated Hepatitis C Virus-related Cirrhosis in HIV-infected Patients
Jose A. Garcia-Garcia*1, M Aguilar-Guisado2, A Rivero3, J Giron-Gonzalez4, M Gonzalez-Serrano5, D Merino6, M Rios-Villegas7, J Macias1, J Gomez-Mateos1, J Pineda1, and for the Grupo para el Estudio de las Hepatitis Víricas de la SAEI
1Hosp Univ de Valme, Seville, Spain; 2Hosp Univ Virgen del Rocio, Seville, Spain; 3Hosp Univ Reina Sofia, Cordoba, Spain; 4Hosp Puerta del Mar, Cadiz, Spain; 5Hosp Univ Virgen de la Victoria, Malaga, Spain; 6Hosp Juan Ramon Jimenez, Huelva, Spain; and 7Hosp Univ Virgen de la Macarena, Seville, Spain |
1060
|
Use of Serum Markers to Assess Progression of Liver Disease in HIV HCV-co-infected Women
K Bambha1, A French2, C Pierce3, E Seaberg3, H Strickler4, A Howard4, G Sharp5, P Tien1, Marion Peters*1, and WIHS
1Univ of California, San Francisco, US; 2Stroger Hosp of Cook County, Chicago, IL, US; 3Johns Hopkins Univ, Baltimore, MD, US; 4Albert Einstein Coll of Med, Bronx, NY, US; and 5NIAID, NIH, Bethesda, MD, US |
1061
|
Association of HIV Infection and HIV/HCV Co-infection with C-reactive Protein Levels: The FRAM Study
J Reingold1,2, C Wanke3, D Kotler4, C Lewis5, S Heymsfield6, P Tien1,2, P Bacchetti1, R Scherzer2, Carl Grunfeld*1,2, M Shlipak1,2, and FRAM study
1Univ of California, San Francisco, US; 2VAMC, San Francisco, CA, US; 3Tufts Univ, Boston, MA, US; 4St Luke`s Roosevelt Hosp, New York, NY, US; 5Univ of Alabama at Birmingham, US; and 6Merck Res Labs, Rahway, NJ, US |
1062
|
Prognostic Factors of Mortality in HCV/HIV-co-infected Liver Transplant Recipients: The FIPSE OLT-HIV-05 - GESIDA 45-05 Cohort Study
Jose Miro*1, M Montejo2, L Castells3, A Rafecas4, P Miralles5, J Fortun6, M Blanes7, M De La Mata8, F Torres1, A Rimola1, and Spanish Olt In Hiv-infected Patients Working Group
1Hosp Clin-IDIBAPS, Univ of Barcelona, Spain; 2Hosp Cruces, Bilbao, Spain; 3Hosp Univ Vall d`Hebron, Barcelona, Spain; 4Hosp Univ de Bellvitge, Barcelona, Spain; 5Hosp Gregorio Maranon, Madrid, Spain; 6Hosp Ramon y Cajal, Madrid, Spain; 7Hosp La Fe, Valencia, Spain; and 8Hosp Univ Reina Sofia, Cordoba, Spain |
1063
|
High HIV DNA Intrahepatic Content Is Associated With a More Severe Liver Disease in HIV/HCV-co-infected Patients with High HIV Viremia than Aviremic HIV/HCV-co-infected Patients
G Sitia1, A De Bona1, F Canducci2, Caterina Uberti-Foppa*1, M Marinozzi2, L Galli1, M Clementi2, L Guidotti1, and A Lazzarin1,2
1San Raffaele Sci Inst, Milan, Italy and 2Univ Vita-Salute San Raffaele, Milan, Italy |
1064
|
Hepatic Venous Pressure Gradient Is Lower in HIV/HCV-co-infected than in HCV-mono-infected Cirrhotic Patients
O Lo Lacono, Juan Berenguer*, D Rincon, P Miralles, A Hernando, M Sanchez-Conde, J Gomez, J Lopez, E Alvarez, and R Banares
Hosp Gregorio Maranon, Madrid, Spain |
1065
|
Factors Associated with Lack of Serological Responses to HIV and HCV in Co-infected Patients with Profound Immunosuppression
C Toro, A Simon, A Amor, V Jimenez, P Rios, and Vincent Soriano*
Hosp Carlos III, Madrid, Spain |
1066
|
HCV Spreads among HIV+ Men Who Have Sex with Men: Evidence of Separate Sexual Transmission Networks in Europe and Australia
Thijs van de Laar*1, M Danta2,3, S Bhagani2, M L Chaix4, G Dore3, M Nelson5, M Prins1,6, M Vogel7, P White3, R Coutinho1,6,8, and HIV and Acute HCV group
1Hlth Svc, Amsterdam, The Netherlands; 2Royal Free and Univ Coll London, UK; 3Univ of New South Wales, Sydney, Australia; 4Hosp Necker, Paris France; 5Chelsea and Westminster Hosp, London, UK; 6Academic Med Ctr, Amsterdam, The Netherlands; 7Univ of Bonn, Germany; and 8Natl Inst of Publ Hlth and the Environment, The Netherlands |
1067
|
CD4 T Lymphocyte Recovery with ART Is Not Directly Influenced by HCV-co-Infection Status
Curtis Cooper*1, B Hutton1, E Mills2, and J Angel1
1Univ of Ottawa and Ottawa Hlth Res Inst, Canada and 2BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada |
1068
|
The Effect of Vicriviroc upon HCV Viral Load in HIV/HCV-co-infected Patients Receiving a Ritonavir-containing Protease Inhibitor Regimen
Gerd Fatkenheuer*1, C Hoffmann2, J Slim3, R Rouzier4, A Sansone-Parsons5, M Treitel5, C Kasserra5, A Keung5, E O'Mara5, and D Schurmann6
1Univ of Cologne, Germany; 2Univ Kiel, Germany; 3St Michael`s Med Ctr, Newark, NJ, US; 4CentreCap, Montpellier, France; 5Schering-Plough Res Inst, Kenilworth, NJ, US; and 6Med Univ of Berlin, Germany |
1069
|
HCV Co-infection Does Not Influence the CD4 Cell Recovery in HIV-1-infected Patients with Maximum Virologic Suppression: EuroSIDA Cohort
Lars Peters*1, A Mocroft2, V Soriano3, J Rockstroh4, P Aldins5, M Losso6, L Valerio7, P Reiss8, B Ledergerber9, J Lundgren1, and The EuroSIDA Study Group
1Copenhagen HIV Prgm, Univ of Copenhagen, Denmark; 2Royal Free and Univ Coll Med Sch, London, UK; 3Hosp Carlos III, Madrid, Spain; 4Univ of Bonn, Germany; 5Infectology Ctr of Latvia, Riga; 6Hosp JM Ramos Mejia, Buenos Aires, Argentina; 7Ctr Hosp Univ Nice, Hosp de l`Archet, France; 8Academic Med Ctr, Amsterdam, The Netherlands; and 9Univ Hosp Zurich, Switzerland |
|
